21217 ⎘
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen; Proteins Heat shock proteins
IMMUNOSTIMULATORY PREPARATION AND COSMETIC, FOOD, FEED ADDITIVE, AND QUASI-PHARMACEUTICAL PRODUCT CONTAINING THE IMMUNOSTIMULATORY PREPARATION
#2CARRIER PROTEIN WITH SITE-DIRECTED MUTATION AND USE THEREOF IN PREPARATION OF VACCINE
#3EX VIVO ANTIGEN-PRESENTING CELLS OR ACTIVATED CD-POSITIVE T CELLS FOR TREATMENT OF CANCER
#4Immunogenic Antigens
#5ANTIGENIC POLYPEPTIDES AND METHODS OF USE THEREOF
#6Immunogenic Antigens
#7Heat Shock Protein-Binding Peptide Compositions And Methods Of Use Thereof
#8Method for rescuing and producing a virus in avian cells
#9epitopes for T cell-targeted Q fever vaccines
#10ANTI-CANCER DNA VACCINE EMPLOYING PLASMIDS ENCODING SIGNAL SEQUENCE, MUTANT ONCOPROTEIN ANTIGEN, AND HEAT SHOCK PROTEIN
#11VACCINES FOR TREATMENT AND PREVENTION OF CANCER
#12EX VIVO ANTIGEN-PRESENTING CELLS OR ACTIVATED CD-POSITIVE T CELLS FOR TREATMENT OF INFECTIOUS DISEASES
#13Heat shock protein-binding peptide compositions and methods of use thereof
#14Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological disease
#15Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer
#16Vitamin D, heat shock proteins, and glutathione for the treatment of chronic inflammation and chronic diseases
#17METHODS FOR PREPARING AND USING MULTICHAPERONE-ANTIGEN COMPLEXES
#18METHODS FOR TREATING CANCER
#19Chimeric molecule useful in immunotherapy for leishmaniasis, which includes a fragment of the PFR1 protein of leishmania infantum with specific immunodominant epitopes
#20Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells
#21Methods of treating and preventing influenza infections
#22Antigen peptide complex for improved production of anti-peptide antibodies
#23Composite antigenic sequences and vaccines
#24Personal Vaccine and Method of Making
#25Immunogenic compositions and methods
#26Immunity enhancing therapeutic vaccine for HPV and related diseases
#27COMBINATIONS OF AGGREGATING PROTEINS AND MOLECULAR CHAPERONE PROTEINS FOR THE TREATMENT OF PROTEINOPATHIES OR CONFORMATIONAL DISEASES
#28Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells
#29Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
#30Immunogenic compositions and methods
#31Chimeric molecule useful in immunotherapy for leishmaniasis, which includes a fragment of the PFR1 protein of leishmania infantum with specific immunodominant epitopes
#32Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
#33Production of anti-peptide antibodies
#34Polypeptides with affinity for heat shock proteins (HSPS) and HSP associated complexes (HACS) and their use in diagnosis and therapy
#35Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological disease
#36Composite antigenic sequences and vaccines
#37Immunogens for treatment of neoplastic and infectious disease
#38Nucleic acids encoding GAS57 mutant antigens
#39METHODS FOR PREPARING AND USING MULTICHAPERONE-ANTIGEN COMPLEXES
#40USING HEAT SHOCK PROTEINS TO IMPROVE THE THERAPEUTIC BENEFIT OF A NON-VACCINE TREATMENT MODALITY
#41Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
#42Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis
#43HIV/SIV VACCINES FOR THE GENERATION OF MUCOSAL AND SYSTEMIC IMMUNITY
#44Heat shock protein GP96 vaccination and methods of using same
#45BIOACTIVE PURIFIED HSPE7 COMPOSITIONS
#46GAS57 mutant antigens and GAS57 antibodies
#47Vaccine for alzheimer's disease
#48PROTEIN CAGES AND THEIR USES
#49Anticancer Combination Therapies
#50INDUCING IMMUNE-MEDIATED TUMOR CELL DEATH
#51Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
#52Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological disease
#53Complexes Derived from Heterohybrid Cells and Uses Thereof
#54METHODS AND COMPOSITIONS CONTAINING mTOR INHIBITORS FOR ENHANCING IMMUNE RESPONSES
#55Material with immunogenicity
#56Heat shock proteins from and uses thereof
#57Tumor cell-based cancer immunotherapeutic compositions and methods
#58Vaccines comprising multimeric HSP60 peptide carriers
#59Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
#60Compositions and methods for using CA9 protein to stimulate an immune response
#61Recombinant Subunit Vaccine
#62Immunogenic compositions and methods
#63PROTEIN CAGE IMMUNOTHERAPEUTICS
#64Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
#65HSP60 from arthrobacter
#66Dendritic cells loaded with heat shocked melanoma cell bodies
#67Compositions of Hsp60 Peptides and Viral Antigens for Vaccination and Diagnosis
#68Heat shock protein-based vaccines and immunotherapies
#69HPV DNA Vaccines and Methods of Use Thereof
#70Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope
#71GRP94-BASED COMPOSITIONS AND METHODS OF USE THEREOF
#72Dendritic Cells Loaded with Heat Shocked Melanoma Cell Bodies
#73Dendritic Cells Loaded with Heat Shocked Melanoma Cell Bodies
#74Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
#75Anti-cancer DNA Vaccine Employing Plasmids Encoding Mutant Oncoprotein Antigen and Calreticulin
#76Use of recombinant heat shock protein complexed to kidney cancer antigen
#77Human papilloma virus treatment
#78IMMUNE RESPONSES AGAINST HPV ANTIGENS ELICITED BY COMPOSITIONS COMPRISING AN HPV ANTIGEN AND A STRESS PROTEIN OR AN EXPRESSION VECTOR CAPABLE OF EXPRESSION OF THESE PROTEINS
#79Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex
#80COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF FUNGAL DISEASES
#81Innate immune system-directed vaccines
#82Heat shock proteins from and uses thereof
#83Methods for the Elimination of Pathogens and Other Particulate Agents
#84Vaccines
#85Immunogen, composition for immulogical use and process for producing antibody using the same
#86Molecular vaccines employing nucleic acid encoding anti-apoptotic proteins
#87Stress proteins and uses therefor
#88Stress proteins and uses therefor
#89Dendritic cells loaded with heat shocked melanoma cell bodies
#90Hsp60 from arthrobacter
#91Heat shock fusion-based vaccine system
#92Fusion protein comprising bacillus calmette guerin heat shock protein 65 and the epitope of human prostate specific antigen
#93Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
#94GRP94-based compositions and methods of use thereof
#95Methods and compositions for impairing multiplication of HIV-1
#96Vaccine against microbial pathogens
#97Method of producing and using heat shock proteins
#98Heat shock protein-based vaccines and immunotherapies
#99Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
#100Heat shock protein-based vaccines and immunotherapies
#101Method and composition
#102Methods for recovering peptides from stress protein-peptide complexes
#103Stress proteins and uses therefor
#104Hepatitis B virus treatment
#105GRP94-based compositions and methods of use thereof
#106Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
#107Recombinant fusion proteins comprising BCG heat shock protein 65 and the epitope of MUC1